SYSTEMATIC REVIEW article
Front. Pharmacol.
Sec. Ethnopharmacology
Volume 16 - 2025 | doi: 10.3389/fphar.2025.1389746
Efficacy and Safety of Danhong Injection on Inflammatory Factors and Vascular Endothelial Function in Patients with Unstable Angina Pectoris: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
Provisionally accepted
- Shandong University of Traditional Chinese Medicine, Jinan, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Inflammatory factors and vascular endothelial damage are significantly involved in the development of unstable angina pectoris (UAP). Danhong injection (DHI) is a compound injection composed of Salvia miltiorrhiza and Carthamus tinctorius extracts. Several clinical studies have demonstrated DHI's efficacy for treating UAP, with potential pharmacological effects on inflammatory factors and vascular endothelial function. However, to date, the current evidence has not been systematically summarized and analyzed.Purpose: This study provides a comprehensive overview of the most recent clinical findings and systematically analyzes the impact of DHI on inflammatory factors and vascular endothelial function among individuals diagnosed with UAP.We searched for randomized controlled trials (RCTs) conducted until January 2023 from two clinical trial registries and eight literature databases. The Cochrane Risk of Bias Tool 2.0 was utilized to assess the potential bias in the included trials, while the GRADE system was employed to evaluate the outcome quality.We included 46 trials involving 4,601 patients with UAP. The meta-analysis results suggested that DHI significantly reduced the levels of high-sensitivity C-reactive protein (hs-CRP) (standard mean difference [SMD]=1.34, 95% confidence interval [CI] [-1.77, -0.90], P<0.00001), tumor necrosis factor-alpha (TNF-α) (SMD=-0.84, 95% CI [-1.54, -0.15], P=0.02), interleukin-6 (IL-6) (SMD=-1.05, 95% CI [-1.86, -0.25], P=0.01), endothelin/endothelin-1 (ET/ET-1) (SMD=-2.01, 95% CI [-2.57, -1.46], P<0.00001), and homocysteine (Hcy) (SMD=-0.55, 95% CI [-0.71, -0.39], P<0.00001) but increased the nitric oxide (NO) level (SMD=1.51, 95% CI [1.04, 1.97], P<0.00001) in patients with UAP. Twenty-one RCTs described adverse events.DHI effectively and safely reduced hs-CRP, TNF-α, IL-6, ET/ET-1, and Hcy levels and increased the NO level in patients with UAP. However, considering the overall low quality of the original studies, future large-scale, high-quality RCTs are imperative to provide robust evidence for clinical practice.
Keywords: Danhong injection, Unstable angina pectoris, Inflammatory factors, Vascular endothelial function, Meta-analysis
Received: 22 Feb 2024; Accepted: 02 Jun 2025.
Copyright: © 2025 Kan, Yan, Chen, Gao and Song. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Yongmei Song, Shandong University of Traditional Chinese Medicine, Jinan, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.